Skip to main content
Retour
Watch Compare

ImageneBio, Inc.

Qualité des données : 100%
IMA
Nasdaq Manufacturing Chemicals
4,90 €
▲ 0,15 € (3,20%)
Cap. Boursière: 53,69 M
Prix
4,80 €
Cap. Boursière
53,69 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue declined -59,91% annually over 5 years
Negative free cash flow of -47,84 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 31,36%

Croissance

Revenue Growth (5Y)
-59,91%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-91,27%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-35,47%
Au-dessus de la moyenne du secteur (-53,34%)
ROIC-28,50%
Net Margin-5668,63%
Op. Margin-6056,38%

Sécurité

Debt / Equity
N/A
Current Ratio13,24
Interest CoverageN/A

Valorisation

PE (TTM)
-1,18
Au-dessus de la moyenne du secteur (-1,47)
P/B Ratio0,38
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -1,2 -1,5
P/B 0,4 1,6
ROE % -35,5 -53,3
Net Margin % -5668,6 -41,5
Rev Growth 5Y % -59,9 1,8
D/E — 0,3

Objectif de Cours des Analystes

2 analystes
Hold
Actuel
4,90 €
+226.4%
Objectif
16,00 €
2,00 €
16,00 €
30,00 €
Prévisions
P/E Prévisionnel -1,46
BPA Prévisionnel -3,37 €
CA Est. 0,0

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -3,37 €
-3,92 € – -2,81 €
 0,0 2
FY2026 -3,86 €
-5,17 € – -2,54 €
 0,0 2

Surprises de Résultats

Derniers 3 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -1,15 € N/A —
Q32025 -1,00 € -2,91 € -191,0%
Q22025 N/A -4,46 € —

ETFs Holding This Stock

BRUSX BRUSX
0,03% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -91,27% Revenue Growth (3Y) -70,45%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -59,91% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 800 000,0 Net Income (TTM) -45,35 M
ROE -35,47% ROA -31,60%
Gross Margin N/A Operating Margin -6056,38%
Net Margin -5668,63% Free Cash Flow (TTM) -47,84 M
ROIC -28,50% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 13,24
Interest Coverage N/A Asset Turnover 0,01
Working Capital 136,39 M Tangible Book Value 139,83 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,18 Forward P/E N/A
P/B Ratio 0,38 P/S Ratio 67,11
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -89,11%
Market Cap 53,69 M Enterprise Value -49,47 M
Per Share
EPS (Diluted TTM) -9,64 Revenue / Share 0,07
FCF / Share -4,28 OCF / Share -4,28
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 105,50%
SBC-Adj. FCF -64,20 M Growth Momentum -31,36

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 800 000,0 9,16 M 9,16 M 15,62 M 30,99 M
Net Income -45,35 M -49,23 M -68,17 M -68,77 M -34,12 M
EPS (Diluted) -9,64 -1,02 -1,63 -1,90 —
Gross Profit — — — — —
Operating Income -48,45 M -58,97 M -75,42 M -70,90 M -34,14 M
EBITDA — — — — —
R&D Expenses 28,53 M 30,88 M 59,65 M 64,32 M 47,11 M
SG&A Expenses — — — — —
D&A 400 000,0 — — — —
Interest Expense — — — — —
Income Tax -350 000,0 152 000,0 -162 000,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 152,98 M 141,51 M 192,09 M 172,26 M 247,88 M
Total Liabilities 19,84 M 15,58 M 22,34 M 25,29 M 40,00 M
Shareholders' Equity 133,14 M 125,93 M 169,76 M 146,97 M 207,88 M
Total Debt — — — — —
Cash & Equivalents 94,53 M 39,39 M 119,89 M 59,92 M 232,22 M
Current Assets 140,29 M 127,17 M 178,66 M 160,01 M 236,52 M
Current Liabilities 11,23 M 10,78 M 14,21 M 21,50 M 27,19 M